Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2013-07-22 19:51:08 UTC
Update Date2021-09-14 15:45:02 UTC
HMDB IDHMDB0061150
Secondary Accession Numbers
  • HMDB61150
Metabolite Identification
Common NameHydroxyl frovatriptan
DescriptionHydroxyl frovatriptan belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. Hydroxyl frovatriptan is a very strong basic compound (based on its pKa). Hydroxyl frovatriptan is a metabolite of frovatriptan. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine.
Structure
Data?1563866151
SynonymsNot Available
Chemical FormulaC14H19N3O2
Average Molecular Weight261.3196
Monoisotopic Molecular Weight261.147726867
IUPAC Name8-hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide
Traditional Name1-hydroxy-6-(methylamino)-5,6,7,8,8a,9-hexahydro-4bH-carbazole-3-carboxamide
CAS Registry NumberNot Available
SMILES
CNC1CCC2NC3=C(O)C=C(C=C3C2C1)C(N)=O
InChI Identifier
InChI=1S/C14H19N3O2/c1-16-8-2-3-11-9(6-8)10-4-7(14(15)19)5-12(18)13(10)17-11/h4-5,8-9,11,16-18H,2-3,6H2,1H3,(H2,15,19)
InChI KeyWKNUOPLCDMOYFP-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassCarbazoles
Direct ParentCarbazoles
Alternative Parents
Substituents
  • Carbazole
  • Indolecarboxamide derivative
  • Indolecarboxylic acid derivative
  • Dihydroindole
  • 1-hydroxy-4-unsubstituted benzenoid
  • 1-hydroxy-2-unsubstituted benzenoid
  • Aralkylamine
  • Secondary aliphatic/aromatic amine
  • Benzenoid
  • Amino acid or derivatives
  • Carboxamide group
  • Primary carboxylic acid amide
  • Carboxylic acid derivative
  • Secondary aliphatic amine
  • Azacycle
  • Secondary amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organic nitrogen compound
  • Amine
  • Organopnictogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.46 g/LALOGPS
logP0.66ALOGPS
logP-0.69ChemAxon
logS-2.8ALOGPS
pKa (Strongest Acidic)9.49ChemAxon
pKa (Strongest Basic)10.48ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area87.38 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity74.94 m³·mol⁻¹ChemAxon
Polarizability28.93 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+163.21331661259
DarkChem[M-H]-161.75531661259
DeepCCS[M+H]+163.39530932474
DeepCCS[M-H]-161.03730932474
DeepCCS[M-2H]-194.22230932474
DeepCCS[M+Na]+169.56930932474
AllCCS[M+H]+162.532859911
AllCCS[M+H-H2O]+158.932859911
AllCCS[M+NH4]+165.932859911
AllCCS[M+Na]+166.832859911
AllCCS[M-H]-165.632859911
AllCCS[M+Na-2H]-165.532859911
AllCCS[M+HCOO]-165.532859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Hydroxyl frovatriptanCNC1CCC2NC3=C(O)C=C(C=C3C2C1)C(N)=O3993.3Standard polar33892256
Hydroxyl frovatriptanCNC1CCC2NC3=C(O)C=C(C=C3C2C1)C(N)=O2681.6Standard non polar33892256
Hydroxyl frovatriptanCNC1CCC2NC3=C(O)C=C(C=C3C2C1)C(N)=O2855.3Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Hydroxyl frovatriptan,1TMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(N)=O)C=C3C2C12771.0Semi standard non polar33892256
Hydroxyl frovatriptan,1TMS,isomer #2CNC1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C)C=C3C2C12791.3Semi standard non polar33892256
Hydroxyl frovatriptan,1TMS,isomer #3CN(C1CCC2NC3=C(O)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C2810.0Semi standard non polar33892256
Hydroxyl frovatriptan,1TMS,isomer #4CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C2735.7Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N[Si](C)(C)C)C=C3C2C12813.5Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N[Si](C)(C)C)C=C3C2C12660.0Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N[Si](C)(C)C)C=C3C2C13638.8Standard polar33892256
Hydroxyl frovatriptan,2TMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C2837.6Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C2688.6Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C3746.5Standard polar33892256
Hydroxyl frovatriptan,2TMS,isomer #3CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2716.1Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #3CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2565.2Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #3CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C3316.2Standard polar33892256
Hydroxyl frovatriptan,2TMS,isomer #4CN(C1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2885.1Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #4CN(C1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2752.2Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #4CN(C1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C3813.0Standard polar33892256
Hydroxyl frovatriptan,2TMS,isomer #5CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C2780.6Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #5CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C2604.4Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #5CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C3216.6Standard polar33892256
Hydroxyl frovatriptan,2TMS,isomer #6CNC1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C12838.3Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #6CNC1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C12775.3Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #6CNC1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C13813.7Standard polar33892256
Hydroxyl frovatriptan,2TMS,isomer #7CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C2812.4Semi standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #7CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C2642.0Standard non polar33892256
Hydroxyl frovatriptan,2TMS,isomer #7CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C3456.7Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #1CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2868.0Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #1CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2772.6Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #1CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C3488.9Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #2CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2782.1Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #2CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2652.1Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #2CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C3018.3Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #3CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C12842.2Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #3CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C12809.2Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #3CNC1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C13492.2Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2760.0Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2654.7Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C3266.7Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #5CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C2828.5Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #5CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C2717.2Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #5CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C3135.1Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #6CN(C1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2961.2Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #6CN(C1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2875.3Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #6CN(C1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C3572.5Standard polar33892256
Hydroxyl frovatriptan,3TMS,isomer #7CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C2787.4Semi standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #7CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C2756.8Standard non polar33892256
Hydroxyl frovatriptan,3TMS,isomer #7CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C3105.3Standard polar33892256
Hydroxyl frovatriptan,4TMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2834.0Semi standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2728.8Standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2988.6Standard polar33892256
Hydroxyl frovatriptan,4TMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2922.7Semi standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C2904.8Standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C)C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3C2C1)[Si](C)(C)C3363.2Standard polar33892256
Hydroxyl frovatriptan,4TMS,isomer #3CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2788.5Semi standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #3CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2800.5Standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #3CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C2953.7Standard polar33892256
Hydroxyl frovatriptan,4TMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C2874.7Semi standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C2857.5Standard non polar33892256
Hydroxyl frovatriptan,4TMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C3057.4Standard polar33892256
Hydroxyl frovatriptan,5TMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2863.1Semi standard non polar33892256
Hydroxyl frovatriptan,5TMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2871.8Standard non polar33892256
Hydroxyl frovatriptan,5TMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C2914.2Standard polar33892256
Hydroxyl frovatriptan,1TBDMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(N)=O)C=C3C2C13008.9Semi standard non polar33892256
Hydroxyl frovatriptan,1TBDMS,isomer #2CNC1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C13058.5Semi standard non polar33892256
Hydroxyl frovatriptan,1TBDMS,isomer #3CN(C1CCC2NC3=C(O)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C(C)(C)C3032.4Semi standard non polar33892256
Hydroxyl frovatriptan,1TBDMS,isomer #4CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C(C)(C)C2998.1Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C13248.4Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C13160.3Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #1CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C13677.6Standard polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C(C)(C)C3285.2Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C(C)(C)C3193.7Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(N)=O)C=C3C2C1)[Si](C)(C)C(C)(C)C3782.6Standard polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #3CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3191.8Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #3CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3055.4Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #3CNC1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3449.1Standard polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #4CN(C1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3355.8Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #4CN(C1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3278.3Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #4CN(C1CCC2NC3=C(O)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3835.8Standard polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #5CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C3260.8Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #5CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C3106.5Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #5CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C3372.4Standard polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #6CNC1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C13310.8Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #6CNC1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C13253.1Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #6CNC1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C13805.6Standard polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #7CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3314.4Semi standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #7CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3138.8Standard non polar33892256
Hydroxyl frovatriptan,2TBDMS,isomer #7CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3557.1Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #1CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3526.2Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #1CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3476.8Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #1CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3645.4Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #2CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3389.7Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #2CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3334.3Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #2CNC1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3309.7Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #3CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C13484.8Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #3CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C13478.7Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #3CNC1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C13610.9Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3448.3Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3323.3Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(N)=O)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3481.6Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #5CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3555.6Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #5CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3415.3Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #5CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3405.9Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #6CN(C1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3600.1Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #6CN(C1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3569.4Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #6CN(C1CCC2NC3=C(O)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3703.8Standard polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #7CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C3474.4Semi standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #7CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C3425.9Standard non polar33892256
Hydroxyl frovatriptan,3TBDMS,isomer #7CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C3337.5Standard polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3682.6Semi standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3542.2Standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3363.6Standard polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3764.6Semi standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3750.9Standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #2CN(C1CCC2NC3=C(O[Si](C)(C)C(C)(C)C)C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C3C2C1)[Si](C)(C)C(C)(C)C3607.0Standard polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #3CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3576.6Semi standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #3CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3618.3Standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #3CNC1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C3280.4Standard polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3761.0Semi standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3679.4Standard non polar33892256
Hydroxyl frovatriptan,4TBDMS,isomer #4CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3358.3Standard polar33892256
Hydroxyl frovatriptan,5TBDMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3877.5Semi standard non polar33892256
Hydroxyl frovatriptan,5TBDMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3800.1Standard non polar33892256
Hydroxyl frovatriptan,5TBDMS,isomer #1CN(C1CCC2C(C1)C1=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3323.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Hydroxyl frovatriptan GC-MS (Non-derivatized) - 70eV, Positivesplash10-001m-1390000000-7a688b0b36d41796922f2017-09-20Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Hydroxyl frovatriptan GC-MS (1 TMS) - 70eV, Positivesplash10-02t9-2096000000-c7f6d58d8dbbf95778bf2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Hydroxyl frovatriptan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 10V, Positive-QTOFsplash10-03dj-0090000000-40ee30e396aaf84f59b32017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 20V, Positive-QTOFsplash10-00kb-0090000000-64fda8b976eb42a41a262017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 40V, Positive-QTOFsplash10-0fsr-5980000000-9bd26fabe0001e1bf20e2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 10V, Negative-QTOFsplash10-03di-0090000000-113afa15a1c47b0739212017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 20V, Negative-QTOFsplash10-03di-1090000000-691f5ace7ebbb4e4e3242017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 40V, Negative-QTOFsplash10-0006-9210000000-9fe9e83af333a8739fa02017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 10V, Negative-QTOFsplash10-03di-0090000000-93a1e2c4d26b43b26bac2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 20V, Negative-QTOFsplash10-03di-0090000000-134c370a4483fbeb3d132021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 40V, Negative-QTOFsplash10-052u-4890000000-1919acfc8aab7d1822022021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 10V, Positive-QTOFsplash10-03di-0090000000-931ff657f2b477bc1cc02021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 20V, Positive-QTOFsplash10-03dj-0090000000-9bbafa691511f5cacd662021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Hydroxyl frovatriptan 40V, Positive-QTOFsplash10-01qi-0950000000-35589415770fc1a35a7a2021-09-23Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound131770051
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available